Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663

Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663

Yuqing Gu, Bin Zhang, Guangliang Gu, Xiaojun Yang, Zhuyin Qian Pancreas Center, The Second Affiliated Hospital to Nanjing Medical University, Nanjing 210003, People’s Republic of ChinaCorrespondence: Zhuyin Qian Email qianzhusilver@163.comBackground: Pancreatic cancer is a devastating mali...

Full description

Bibliographic Details
Main Authors: Gu Y, Zhang B, Gu G, Yang X, Qian Z
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
metformin
pancreatic cancer
emt
dna methylation
mir-663
Online Access:https://www.dovepress.com/metformin-increases-the-chemosensitivity-of-pancreatic-cancer-cells-to-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/metformin-increases-the-chemosensitivity-of-pancreatic-cancer-cells-to-peer-reviewed-article-OTT

Similar Items